Search results
Results from the WOW.Com Content Network
Respiratory syncytial virus (RSV), [a] also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. [2] Its name is derived from the large cells known as syncytia that form when infected cells fuse. [2] [3]
The CDC estimates between 58,000 and 80,000 U.S. children under 5 are hospitalized with RSV every year, resulting in 100 to 300 U.S. kids under 5 dying, though other estimates are much higher.An ...
“RSV enters the body through the mouth, nose or eyes, and spreads easily through the air,” she says, explaining the reasoning why these two actions go a long way in protecting against the virus.
“RSV is a common and pervasive cause of acute respiratory illness that is highly contagious and usually affects an individual’s lungs and airways,” said Bill Gruber, MD, Senior Vice ...
RSV, or respiratory syncytial virus, can affect anyone with “cold-like” symptoms and has the potential to be most severe for babies and older adults, according to the CDC. The most common ...
In cases of viral pneumonia where influenza A or B are thought to be causative agents, patients who are seen within 48 hours of symptom onset may benefit from treatment with oseltamivir, or zanamivir, or peramivir. [13] Respiratory syncytial virus (RSV) has no direct acting treatments, but ribavirin is indicated for severe cases. [13]
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. [1] RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. [2] The RSV vaccines Arexvy , [3] Abrysvo , [4] and Mresvia [5] are approved for medical use in the United States.
For premium support please call: 800-290-4726 more ways to reach us